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The  first  comprehensive  investigations  of  the  antigenic  composition  of various 
virus  isolates  from epidemics  of influenza  A  demonstrated  the  complex nature  of 
the  immunologic problems  to  be  considered  with  this  disease  (1-4).  These  data, 
obtained by mouse protection tests,  portrayed antigenic variation and, in addition, 
were  clearly interpreted  as  evidence  of shared  antigens  among the  strains  of in- 
fluenza virus then available (2, 3). It was pointed out that they represented a spectrum 
of interrelationships  and that all strains did not fit readily even into loosely defined 
groups.  Certain  investigators  (4),  however, attempted  to classify groups of strains 
in terms of types or "master" strains. 
With the advent of hemagglutination-inhibition technics emphasis has again been 
toward  relating  all  isolates  to  prototype  strains  (5-7).  Recently  Magill  (8)  and 
Hilleman  (9)  have  classified  strains  by hemagglutination-inhibition  with  rabbit  or 
chicken sera prepared  against a  limited number of strains employed as prototypes. 
Although the sera are commonly prepared in a manner which emphasizes the domi- 
nant antigen of a  strain,  they may still contain antibody to its lesser antigens. The 
results,  therefore, do not indicate whether the reaction of a  test strain with a given 
serum is the result of antibody to a single dominant antigen or to several components 
shared with the prototype strain.  Hence, many differences  and relationships among 
strains may not be evident. 
A promising approach to a  more precise definition of antigenic components is by 
absorption of antibodies  from sera.  That  antibodies  against influenza virus can be 
absorbed from serum has been repeatedly demonstrated  (7,  10-15). Friedewald  (12) 
found antibody absorption tests  to be valuable in studying the antigenic composi- 
tion of influenza virus and concluded that quantitative as well as qualitative differ- 
ences in components provided antigenic distinction  to strains.  Hirst  (15)  absorbed 
crossing antibodies  from rabbit  hyperimmune  sera  and  typed  strains  by their  in- 
hibition with sera absorbed  so as to make  them relatively specific  for one of eight 
selected  strains.  This procedure  tends  to ignore  the  composite antigenic  structure 
of influenza virus and demonstrates only that antigen shared with the prototype strain. 
The foregoing review summarizes trends which emphasize either similarities 
or differences among strains and indicates the necessity of adequately mapping 
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the  antigenic  constitution  for a  comprehensive  understanding  of strain  rela- 
tionships.  It has  been indicated  that  quantitative  absorption procedures are 
an  effective logical approach  to  the  problem  but  have  been  limited  in  their 
application  by the  technical burdens involved in preparation  of concentrated 
antigenic masses, in separation of added virus from absorbed serum, and by the 
difficulty of establishing  quantitative  standards  of absorption  by antigens. 
The  demonstration  in  this  laboratory  (16)  that  influenza  virus  adsorbed 
to erythrocytes can function efficiently to absorb antibody from serum stimu- 
lated  the  development  of  procedures  for  ensuring  stable  erythrocyte-virus 
complexes.  The absorption of antibodies from sera is thus greatly facilitated. 
Information concerning different  components which may be shared  can  then 
be derived by a systematic investigation of the antibodies absorbed by homolo- 
gous and heterologous strains. Comparisons of the qualitative and quantitative 
capacity of the analyzed strain to absorb defined amounts of homologous and 
heterologous antibody from a  standard serum mixture  give accurate informa- 
tion  concerning shared  components.  Standardization  of the  antibody-absorp- 
tive  capacity of each lot of virus-coated cells  against  the  homologous serum 
provides  a  standard  for  comparison  so  that  antigenic  composites  or profiles 
of the strains of influenza virus can then be mapped. The information so ob- 
tained constitutes the basis of this report. 
Materials and Methods 
Procedures for Absorption of Antibody.--The union  between  erythroeytes  and influenza 
virus offers a unique approach for the absorption of virus-specific antibody from serum. Virus 
held by other absorbents  (norite, celite, calcium phosphate,  etc.) may unite with the anti- 
body, but the non-specific absorption of antibody by these chemicals makes them tmsnitable. 
Unfortunately  the equilibrating nature of the reaction between erythrocyte and active virus 
does not permit formation of a stable red cdl-virns complex. Virus particles that have been 
inactivated  by heat will adsorb firmly to erythrocytes  (14, 16-18), but tmiform inactivation 
of viral populations is difficult to obtain with heat. On the other hand, treatment of either the 
virus  or the erythrocytes  with periodate  consistently  yields irreversible adsorption  of the 
virus to the cell receptor (19-21). Treatment of erythrocytes with perindate was studied in a 
series of experiments but was discontinued when it became apparent that such cells were not 
readily coated with a sufficient concentration of virus to effect complete absorption of anti- 
body. Experiments with periodate-treated  virus were more rewarding and the method  out- 
lined below was developed. The procedures involved are diagrammed as a flow sheet in Fig. 1. 
(a) Preparation of  Formalinized Erylhrocytes.--Erythrocytes from  human  blood  were 
washed three  times in buffered saline (0.01 m phosphate  in 0.85 per cent sodium chloride, 
pH 7.2), and 50 per cent cell suspensions were mixed with an equal volume of 30 per cent 
formalin. After storage at 4°C. for 48 hours the cells are very cohesive, dark brown masses, 
and the supernatant  fluids are dark red, apparently  due to methemoglobin. The cells were 
then washed 6 to 8 times in buffered saline over a period of several days until  the odor of 
formalin was no longer detectable. The virus materials subsequently added are therefore not 
subjected  to significant concentrations  of formalin. As Flick (22) has shown, such cells are 
extremely stable. In our hands, they resist lysis for several weeks, adsorb influenza virus to a 
maximal degree, and are readily  packed  in the centrifuge. K.  E.  JENSEN  AND  T.  lCRANCIS, JR.  621 
(b)  Preparation and Treatment of Virus.--Pools of 1 to 2 liters of allantoic fluid containing 
a given strain of virus were obtained by inoculating 11-day chick embryos with 0.1 ml. con- 
taiuing approximately 10  ~ EID~o of the desired strain. After incubation at 37°C. for 48 hours 
the eggs were chilled at 4°C. for 2 hours, the fluids harvested with a  suction apparatus, and 
then chritied by low speed centrifugation. The hemaggiutinin titers of these pools vary from 
1:160 to 1:1280 by a  standard pattern method (23) with 0.5 per cent chicken erythrocytes. 
Pools were mixed with an equal volume of M/25 potassium periodate solution in buffered 
saline and held at room  temperature for  1 hour.  The excess periodate was neutralized by 
VIRUS TREATMENT  ERYTHROCYTE TREATMENT 
Virus in allantoic  fluid I  rHuman erythrocytes 
KI04 (O.02M), I hour [~  AFormalin(15%), 48 hOUrS 
Glucosa(lO~),  I/4 hourJ  ~  times  LWashed  in buffered  saline,  6-8 
Virus adsorbed  to cells 
Washedin buffe!ed saline, 3 times 
Immune serum 
Sedimqmted  virus.cell-antibody  complex 
FIG.  1.  Method for serum absorption. 
one-half volume of 10 per cent glucose. Such treatment destroys the eluting capacity of the 
virus but not its hemagglutinating activity (20). Furthermore there is no evidence that the 
antigenicity of the virus is measurably altered. 
(c) Preparation of RBC-Virus Complex.--lO00  ml.  of  virus suspension in allantoic fluid, 
periodate, and glucose are mixed with 50 ml. of 50 per cent formalinized cells and subjected 
to repeated gentle shaking and then placed at 4°C.  overnight. Estimates of the amount of 
virus adsorbed were made by comparing the hemagglutiuin titers of fluids before and after 
addition of the erythrocytes. When the hemagglutinin titer of the pool was low,  adequate 
concentrations of virus on the cells were obtained by adsorption of the virus from several 1 
liter volumes of fluid with the same lot of erythrocytes. The virus-cell complexes were washed 
3 times in buffered saline and stored at 4°C. as 50 per cent cell suspensions. 
(d)  Preparations of Antisera  and Antibody  Titrations.--All  ferret sera were obtained from 
convalescent animals. Ferrets were infected by intranasal instillation with 2.0 ml. of a  1 : 1000 622  ANTIGENIC COMPOSITION OF INFLUENZA  VIRUS 
dilution in broth of aliantoic fluid containing the selected virus. Blood was obtained by cardiac 
puncture on the day of infection and 2 weeks later.  1 month after the original infection the 
animals were again inoculated intranasally with 2.0 ml. of infected allantoic fluid to enhance 
the antibody response to all antigenic components of the strain of virus. Blood was collected 
on the day of reinoculation and 2 weeks later. Convalescent sera were employed because the 
antigenic stimulus from each antigenic component is probably  more readily realized from 
infection than from vaccination, and difficulties with non-viral antigens are not encountered. 
The standard pattern test (23) was used to titrate hemagglutinin-inhibiting (H-I) antibody. 
Difficulties with non-specific  inhibitors were circumvented by using inhibitor-resistant lines 
of virus and dilutions of serum beyond the range of inhibitor effect. 
Virus-neutralizing  antibodies were titrated  in  o¢o by mixing approximately 500  EID~o 
and serial 4~fold dilutions of serum, incubating at 37°C.  for 30 minutes, and inoculating 0.1 
ml. of each mixture into four 10-day embryonate eggs. After incubation for 72 hours at 37°C. 
0.5 ml. of the allantolc fluid of each egg was tested for virus hemagghitinin with 0.5  ml. of 
0.5 per cent chicken erythrocytes. 
The technic of complement fixation (CF) was similar to that described by Lennette et al. 
(24) except that incubation of the antigen-antibody mixture for 1 hour at 37°C. was substi- 
tuted for overnight at 4°C. 
Acute and convalescent phase sera were tested simultaneously with each strain of virus. 
Antibody titers are expressed  as the reciprocal of the initial dilution in the CF test and of 
final dilutions in the H-I and neutralization tests. 
(e)  Method of Antibody Absoeption.--Erythrocytes  coated with the selected strain of virus 
were sedimented by centrifugation from stock 50 per cent cell suspensions  and resuspended 
in dilutions of serum. The mixtures were heid as routine overnight at 40C., although com- 
parable results have been obtained after 3 hours at room temperature. Cells were then packed 
by light centrlfugation and the H-I antibody titer of the superuatant  serum was compared 
with that of the unabsorbed  serum. In the case of an homologous serum-virus system, es- 
sentially all the homologous H-I antibody is removed. No free hemagglutlnl- should he de- 
tected in either acute or convalescent phase sera absorbed in this manner. That the reduction 
of antibody titer is not merely the effect of virus released from the ceUs is shown by the fact 
that no virus is detected in normal serum so treated. 
(f)  Quantltation  and  Standardization  of  Antlbody-Absorptice  Capaeity.--The  results  of 
prel~minary absorption experiments indicated the need for quantitation of the antigen-anti- 
body system. In the first experiments the concentration of hemagglutinin on the erythrocytes 
was estimated from titrations of the periodate-treated fluids before and after adsorption to 
formalinized RBC or by direct titration of the hemagghitinin on the virus-coated human cells 
with 0.5 per cent chicken ceils in a pattern test. However, the capacity of the cell-virus com- 
plex to absorb antibody from sera is not measured by these methods.  Results from several 
absorption experiments with many different antigen-antibody  mixtures could be compared 
only when the amounts of absorbent antigens were standardized. The foUowing procedure was 
developed to meet this need. The homologous antibody concentration of a  standard  serum 
for each strain of virus was adjusted by dilution so that the H-I titer would be 1:64. 2.0 ml. 
aliquots of the serum dilutions were mixed with several different volumes (0.12,  0.25,  0.5, 
and  1.0 ml.) of packed virus-coated cells.  Homologous H-I antibody titers of the absorbed 
aliquots of serum were then  determined.  The minimal volume of ceil-virus complex that 
would completely remove the 64 units of homologous H-I antibody in a single absorption was 
defined as one absorbing unit (A.U.). The A.U. volume of a preparation has  been found to 
remain  constant  for several weeks when stored at 4°C. This relative stability therefore pro- 
rides the ohvious advantage of subsequent use in several absorption experiments with relative 
confidence  in the comparability of results. K. E. JENSEN AND T. FRANCIS, JR.  623 
Strains o/Virus.--The 42  strains of Type A influenza virus included in this study were 
selected as representative of isolates from epidemics of the disease occurring since 1933. The 
majority of these strains were from the files of this laboratory and have been described pre- 
vionsly.  The Henry, Hickcox,  Cam, Coamo,  and Netherland 1/49  were  obtained from the 
Strain Study Center of Dr. T. P. Magill. Dr. G. K. Hirst of The Public Health Institute sent 
the Christie strain. Information concerning the date and place of isohtion of each strain is 
given in Table L 
The Type B strains of influenza virus studied included Lee, isolated in Irvington, New York, 
in 1940, and Allen, from Ann Arbor, Michigan, in 1945. 
All strains were well adapted to eggs by passage in the allantoic sac of 11-day chick em- 
bryos. Many strains also had ferret and mouse passages in their histories. 
TABLE I 
Strains o/Type A lnJluenza Virus Studied 
1.  Swine  Iowa  1931".~ 
2.  WS  Eng.  1933".* 
3.  PR8  P. Rico 1934" 
4.  Alaska  Alaska  1935" 
5.  BH  Eng.  1935",~ 
6.  Me1  Austr.  1935".' 
7.  Phila.  Phila.  1935" 
8.  TF  N.Y.  1936" 
9.  NY2  N.Y.  1936',: 
10. Henry  N.Y.  1936".: 
11. Smithb  Eng.  1937 
12.  Gatenby Eng.  1937",i 
13.  Taimey  Eng.  1937".* 
14.  Chris  Eng.  1937" 
15.  Cl12  Europe  1939",~ 
16. Banm  Mich.  1940",~ 
17.  Hick  N.Y.  1940" 
18.  Weiss  Mich.  1943",~ 
19. IA43  Iowa  1943".:~ 
20.  Jacksl  Mich.  1943 
21.  Ian  Anstr.  1946 
22.  Cam  Anstr.  1946" 
23. Leiden Neth.  1947 
24.  FM1  N.J.  1947",:~ 
25. Rhodes Mich.  1947",~: 
26.  FjS  Austr.  1948 
27.  Coamo P. Rico  1948 
28.  Dean  Mich.  1948 
29.  Berry  Mich.  1948 
30.  CA7  Canada 1949" 
31.  Hood  Mich.  1949 
32. O. Is.  O. Is.  1949 
33.  Roma  Rome  1949".~: 
34.  Neth.  Neth.  1949 
35.  Chore  Anstr.  1950 
36. Sweden  Sweden  1950" 
37.  Cup  Wyo.  1950" 
38. Ten  Mich.  1950".~: 
39. Lond  Eng.  1951 
40.  Boch  Mich  1951" 
41.  Mor  Mich.  1951".~ 
42. Jes  Mich.  1953",~: 
*,  attempted preparation of strain-specific  serum  (29 strains). 
~:, successful preparation of strain-specific  serum  (18  strains). 
EXPERIMENTAL 
Absorption  of Antibody  from  Individual  Ferret Sera  by  the  Infecting  Strain 
The  serum  of  a  ferret  convalescent from  infection with  a  given  strain  of 
virus contains antibody to the infecting strain and ordinarily to related heterol- 
ogous strains. Absorption of that serum with the  infecting strain  removes all 
heterologous as well as homologous antibody. Representative examples of this 
observation are presented in Table II. Serum from a  ferret convalescent from 
an infection with the A-prime Rhodes (1947) strain of influenza virus contains 
antibodies that will not only inhibit the Rhodes strain but also reacts with the 
Type A  PR8 (1934)  strain. Mter absorption with the Rhodes strain the super- 
natant serum no longer inhibits either of these strains of virus. This relation- 
ship is also found between the Type B  strains of influenza virus. Thus the anti- 
Allen (1945)  serum also inhibited the Lee (1940)  strain, but the serum did not 624  ANTIGENIC COMPOSITION OF  INFLUENZA  VIRUS 
react with either strain after absorption with the infecting strain. The specificity 
of this reaction is demonstrated by the failure of absorption with strains com- 
pletely different antigenically to have any reducing effect on antibody titers, 
TABLE II 
Antibody Absorption with Flomdogous Strains of Influenza Virns 
Serum  Test viruses 
Infecting strain  Absorption strain  PR8 (1934)  Allen ( 1945 ) 
Rhodes 
Allen 
Nil 
Rhodes 
Lee 
Nil 
Allen 
Rhodes 
6405 
<32 
640 
<32 
<32 
<32 
Rhodes (1947)  Lee (1940) 
2560  <32 
<32  <32 
2560  <32 
<32  320 
<32  <32 
<32  320 
<32 
<32 
<32 
2560 
<32 
2560 
* Reciprocal of final dilution of serum that  inhibits 4 units of hemagglutinating virus. 
TABLE IH 
Complete Removal of Antibody by Absorption with a HeJorologous Strain of Influenza Virus 
Test strains 
Swine (1931) 
WS (1933) 
PR8 (1934) 
Alaska (1935) 
BH (1935) 
Mel (1935) 
TF (1936) 
NY-2 (1936) 
Henry (1936) 
C12 (1939) 
Baum (1940) 
Henry (1946) convalescent serum 
Unabsorbed  Absorbed with TF (1935) 
80 
80 
80 
160 
320 
160 
160 
80 
640 
160 
80 
<40 
<40 
<40 
<40 
<40 
<40 
<40 
<40 
<40 
<40 
<40 
as shown by the absorption of the Rhodes (Type A) convalescent serum with 
the Lee  (Type B)  strain. 
These results are to be expected since the crossing antibodies are presumably 
reacting with antigens shared by the two strains and the entire group of anti- 
genic components is present when the homologous virus is used for absorption. 
Absorption  with  Related  Heterologous  Strains 
The  extent  to  which  antigenic  components  are  shared  among  strains  is 
further emphasized by the results of serum absorption with related heterolo- K. E. fENSEN  AND  T. ~'RANCIS~  JR.  625 
gous  strains  of  influenza  virus.  The  ~tigenic  prominence  of  a  component 
varies among strains so that the results of antibody-absorption from a  given 
serum by different strains will depend upon this relationship.  Absorption with 
one  strain  representing  a  particular  antigenic  mosaic  which  has  multiple 
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Fro. 2. Absorption of Tenney, Moravec, and Jessup ferret  scra.  Sera were initially  diluted 
1:20. Outlined areas indicate  H-I titer  against the various strains  with unabsorbed sera  and 
solid  areas represent  antibody after  absorption. 
components in common with the infecting  strain may produce one of several 
results. 
(a)  All  detectable antibody against  homologous and  heterologous strains 
may be removed  (Table III),  When  the serum of a  ferret which had  been 
infected with the Type A Henry (NY-1936)  strain  is absorbed with the TF 
strain  (NY-1936)  the serum no longer reacts with any of the other 42 strains 
of influenza virus tested. The TF strain apparently contains all the components 626  ANTIGENIC  COMPOSITION  OF  INFLUENZA  VIRUS 
of  the Henry strain  in  sufficient concentrations to  unite with all  the  anti- 
Henry strain antibodies and to leave no antibody that will react with the other 
strains of influenza virus. 
(b)  Absorption of a  serum with a  related heterologous strain may result 
in the complete reduction of all antibody which inhibits the absorbent or other 
heterologous strains, but leaves antibody that will inhibit the infecting strain 
n- 
bJ 
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FIG. 3. Absorption  results with Weiss ferret serum. 
of virus. Fig. 2 summarizes the results of absorbing sera from each of several 
ferrets  convalescent from  infections with  certain  strains  of  virus  that  are 
related in this manner. In each example absorption with the Rhodes strain 
removes all antibody that reacts with heterologous strains, but the serum still 
reacts to high titer with the homologous strain. Here the antigenic complex 
of the absorbent strain shares many of the components of the infecting strains 
but is deficient in at least one component of each of the other strains. This 
allows production  of  strain-specific  sera. 
(c)  Absorption  of  serum  with a  particular  strain  may give  reduction of 
antibody for only some of the  related heterologous strains and again have K.  E.  JENSEN  AND  T.  FRANCIS,  JR.  627 
little effect on the titer of inhibiting antibody for the infecting strain. Succes- 
sive absorption of that serum with two or more selected strains,  however, can 
effect the creation  of a serum that will inhibit only the infecting strain. This 
type of result is illustrated in Fig. 3 with the subsequent production of a serum 
which is specific for the Weiss (1943) strain following absorption  of the ferret 
serum with the PR8 (1934) and Baum (1940) strains.  The effect is obtained 
by either successive or  simultaneous  absorptions with these related strains 
and indicates that the critical  combination of antigenic components  is repre- 
sented in the total antigenic complex of the two absorbent strains. 
(d)  It is also possible that absorption may result in a  serum  that will not 
inhibit  the homologous strain  but  H-I antibody may be  found for certain 
TABLE IV 
Absorption of Homologous Antibody with a Heterologous Strain of Influenza  Virus 
Test strains 
Alaska (1935) 
TF (1936) 
Baum (1940) 
Hickcox (1940) 
Cam (1946) 
Rhodes (1947) 
Tenney (1950) 
Moravec (1951) 
Cam (1946)  convalescent serum 
Unabsorbed 
320 
160 
320 
640 
640 
320 
320 
80 
Absorbed with Hickcox (1940) 
<40 
<40 
<40 
<40 
<40 
80 
<40 
80 
heterologous strains.  An example of this situation is found when the Hickcox 
(1940) is used to absorb  antibody from a  ferret convalescent  from infection 
with the Cam (1946) strain (Table IV). In this case the absorbed  serum does 
not react with the Cam or Hickcox strains but will inhibit the hemagglutinins 
of the  Rhodes  (1947) and Moravec  (1951)  strains of influenza  virus.  It is 
concluded  that  the antigenic composite  of the Hickcox  strain  contains the 
principal  antigens of the Cam strain mosaic  but some antibodies stimulated 
by Cam are relatively less involved,  qualitatively or  quantitatively, in the 
inhibition of the homologous strain than of the Rhodes and Moravec strains. 
Removal of Non-Speclfic Inkibitors by  Absorption 
Observations  from  several  experiments  indicating  that  non-specific  in- 
hibitors (23, 26) might be removed  from serum by absorption with a virus- 
cell complex prompted additional experiments  to investigate this possibility. 
Normal sera  and sera from animals immune to Type A strains of influenza 
virus were absorbed  with the antigenically unrelated Type B Lee strain so as 628  ANTIGENIC COMPOSITION OF INFLUENZA VIRUS 
not  to  disturb  the  antibody.  The  data  presented  in  Table  V  demonstrate 
that absorption of rabbit or ferret sera with the Lee strain invariably removes 
the' materials  that  non-specifically  inhibit  the  hemagglutinin  of  the  heat- 
inactivated (inhibitor-indicator virus) Lee strain. 
The  irregular  results  of H-I tests  obtained  with  the  various  lines  of  the 
Wright  (1953)  strain  may be interpreted  as evidence of non-specific hemag- 
glutinin-inhibitory  substances  which  do  not  unite  as  readily  with  the  Lee 
strain of influenza virus and have a  variable effect on  the  hemagglutinin  of 
different  lines  of  this  isolate. 
TABLE V 
Remo'oal of Non-Spedf~ Inhibitors  from Serum by A bsorption with a Virus-Erythrocyte Complex 
Animal sera 
Rabbit 
Immunized with 
Wright (AE1F-a) 
Ferret 
Infected with 
Wright (AE~F_a) 
Phase of bleeding 
Normal 
Immune 
Acute 
Convalescent 
Absorption 
with Lee 
strain 
Nil 
4 A.U. 
Nil 
4 A.U. 
Nil 
4 A.U. 
Nil 
4 A.U. 
Test viruses 
Lee (FaM~t~Eteo) 
Active  :coted 
<325  1024 
<32  <32 
<32  11024 
<32  , <32 
I-- 
<32  512 
<32  ~ <32  I 
<32  512 
<32  i<32 
Wr/ght 
(AEtEu 
256 
<32 
1024 
256 
128 
<32 
512 
256 
Wright 
(MtAE~F~) 
(M~Ed 
512 
<32 
1024 
256 
256 
128 
1024 
1024 
* 56°C. for 30 minutes. 
~; Reciprocal of final dilution of serum that inhibits 4 hemagglutinin units. 
Evidently more than one kind of heat-stable non-specific inhibitory material 
may be found in  sera  as suggested by Chu  (27)  and  Sampaio (26),  but  the 
effect on  hemagglutinin  is  not  necessarily overcome by  adaptation  to  mice 
as was believed by these  investigators. Additional  investigations of the  rela- 
tionship between  the inhibitors acting upon heat-inactivated virus and those 
inhibiting newly isolated strains are indicated. 
Absorption  of  Neutralizing  and  Complement-Fixlng  Antibodies 
Friedewald (12) and Walker and HorsfaU (28) observed a reduction of anti- 
body  titer  as  determined  in  neutralization  and  complement  fixation  tests 
when  antisera  are  treated  with  virus,  and  it  was  of  interest  to  determine 
whether similar results would obtain with the virus-cell complex. The results 
of such an experiment are summarized in Table VI. Antibody absorption was K.  E.  JENSEN  AND  T.  FRANCIS,  JR.  629 
tested with CF and in ovo neutralization tests as well as by H-I tests with the 
sera  of ferrets  convalescent from infection with  Type A  Rhodes  strain  of 
influenza virus.  Absorption  of the  sera  with the infecting strain  completely 
removes  homologous and  heterologous  antibody as  measured  by  all  three 
serologic tests. Absorption with a related heterologous strain of virus (Moravec) 
results in a decreased titer of antibody for the absorbent and other heterologous 
strains,  while the effect on homologous antibody is  less  marked. Again  the 
specificity of absorption in relation to shared antigens is noted, and it is inter- 
esting to find the CF test also reflecting a strain-specific decrease in antibody 
titer following absorption with the heterologous strain. This is surprising since 
that degree of strain specificity is usually not observed with the CF test. 
TABLE VI 
Absorption Results wittt Con~alescent Ferret Serum (Rhodes, 1947) 
Antigens tested after absorption 
Serum Absorbent  (1 absorbed unit)  Rhodes (1947)  Moravec (1951) 
HoI  CF  H-I  CF  E.N. 
Nil 
Rhodes 
Moravec 
E.N° 
4096*  320  [  >5120  512 
m 
<32  <40  ]  <80  <32 
512  8O  2560  <32 
160  640 
<40  <80 
40  <80 
E. N., egg neutralization. 
* Reciprocals of final dilutions of serum. 
Preparation of Strain-Speclfic  Sera 
With an increased understanding of the quantitative aspects of the absorp- 
tion technics devised, a  comprehensive study of the antigenic constitution of 
strains  of  influenza  virus  was  begun.  Exploratory  absorbing  experiments 
promised the preparation of a  series  of sera  that would inhibit only the re- 
spective strains of virus used to infect the animals. Convalescent ferret serum 
was therefore prepared against each of 29 selected Type A strains and cross- 
tested by H-I with all these strains. The serologic relationships between strains 
as defined by these results governed the choice of absorbent strains for the 
preparation of strain-specific sera. In 10 cases absorptions with combinations 
of two beterologous strains resulted in  sera  that would react only with the 
infecting strain. On the other hand, 8 specific sera were produced by absorp- 
tion of beterologous antibody with a  single closely related strain. A summary 
of this aspect of the study is shown in Table I. A  total of 18 strain-specific 
sera were prepared from 29 different convalescent ferret sera and tested with 
42 related strains of virus. The strains with which attempts have been made to 
prepare  specific  serum are  marked with an asterisk,  and  the  double dagger 630  ANTIGENIC COMPOSITION  OF  INFLUENZA  VIRUS 
signs indicate those strains for which the highly specific sera have been pre- 
pared.  Since  18  different strain-specific  sera were demonstrated,  it  suggests 
that  there are at least 18 different antigenic components in the Type A  in- 
fluenza  virus,  and  evidence of other  components is also available from  the 
unsuccessful  attempts  to prepare  strain-specific  sera.  Several sera were pre- 
pared that would react only with  1 or 2 strains  other than  the homologous 
strain which indicates a subgroup of strains sharing a specific antigen. When 
the problems of separation  of these strains  have been solved, an additional 
number of antigenic components may be as readily demonstrated as the  18 
described  above.  The  results  forecast  the  extreme  complexity of  antigenic 
constitution that may eventually be defined for this group of viruses. 
Assay of Antigenic Composition of Strains 
The search for specific antigens is of obvious interest and must be continued, 
but a primary objective was to compare the composite antigenic structures of 
strains of influenza virus. The procedures which had been so fruitful in furnish- 
ing  the  foregoing  were  therefore  adapted  to  this  problem  with  gratifying 
results. If a serum were available which contained equivalent titers of antibody 
to each of the antigenic components, absorption with a  standard  amount of 
any strain of virus would remove antibody to the components present in that 
strain,  and the extent of the absorption of the various antibodies would de- 
scribe the antigenic structure of the test strain. 
For this purpose sera from ferrets convalescent from infection with one of 
17 strains chosen  to represent different components were pooled in such con- 
centration that the pool contained a comparable titer of H-I antibody for each 
of the 17 strains. Therefore the final titer of antibody for each strain represents 
homologous antibody and  the amounts of cross-reacting  antibody furnished 
by the sera against heterologous strains  which contained the same antigens. 
Aliquots of the pool were absorbed with a standard number of absorbing units 
of each virus-cell  complex.  Each aliquot was then  tested for antibody to all 
of the strains represented. The results of absorption with the Rhodes (1947) 
strain are given in Fig. 4. Three successive absorptions with 2 A.U. were carried 
out to investigate the antigenic constitution of the strain and  to establish a 
practical limit for the amount of absorbent antigen to be employed for adequate 
analysis.  The most complete reduction in antibody titer following this absorp- 
tion was for those strains isolated in the years from 1947 to 1950. Antibody 
content was also decreased,  but to a  lesser extent, for several other strains. 
It is concluded that absorption with 6 A.U. is a practical level since only small 
changes in antibody titers were noted between the second and third successive 
absorptions with  2 A.U.  in  this experiment  and  in  several tests with other 
absorbing strains. Antiserum for the Type B, Lee, strain was included in  the 
pool to demonstrate the specificity of the reaction and to control the  dilution 
factors. K. E. .]'ENSEN AND  T. FRANCIS,  .TR. 
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A  diagram  of the  decrease  in  antibody titers following  absorption with 6 
A.U.  gives  a  measure of the  antigenic pattern  of the absorbent strain.  The 
data diagrammed  in this manner  provide a  positive picture of the antigenic 
profile of the virus studied. Profiles observed with the swine, WS, PR8, Cam, 
and Jessup strains are shown in Figs. 5 and 6. High points are seen at the posi- 
tions where the antigenic reflection  is greatest,  and lesser elevations identify 
TABLE VII 
Prominent Antigenic Features 
Antigen representative strains 
Analyzed 
strains 
Swine  (1931)  I"M  1 
WS (1933) 
PR8 (1934) 
Phila (1934) 
Alaska (1935) 
BH (1935) 
Mel (1935) 
Henry (1936)  i 
TF (1936)  Im 
Gat. (1937) 
Hickcox (1940)  Im 
IA43 (1943) 
Weiss (1943) 
Cam (1946) 
FMI (1947) 
Rhodes (1947)  lm 
Berry (1948) 
Roma/2 (1949) 
Cuppett (195O1 
Tenney (1950) 
Sweden/3 
(195o) 
Moravec (1951 
Jessup (1933) 
Wright (1953) 
sw  ws P,g~I  '31 i '33  B1~¢o4 
A1 I A21 ~4!  A4  i 
3m 
22M  m  4m 
3M 1 4m 
2m  3M  4m 
3M I 
3m [ 4M 
4m 
4m 
4m 
4m 
4m 
4m 
3m  i  4m 
3m~  ~ 
3mi 4m 
33:  4m 
4m 
3m i 4m 
3m] 4m 
M, major antigen; reduced antibody titer 16- 64-fold. 
m, minor antigen; reduced antibody titer 4- 8-fold. 
those  components  less  well  expressed.  These  profiles  clearly  demonstrate 
strain differences and simiiafities.  The quantitative variation presented in the 
patterns furnishes an estimate of the relative  concentration  of each antigen 
in the composite virus. Some difficulty is encountered in assessing the signifi- 
cance  of  the  lowest elevation  in  the  diagrams,  however,  because  a  2-fold 
decrease of antibody titer is within the limit of error in the method as demon- 
strated by the results d  absorbing the pool with the Type B Lee strain (Fig. 6). 
Here 2-fold decreases  in antibody titers against several of the representative 
strains were seen.  This may be explained on the basis of absorption of non- 
specific inhibitor as discussed in a previous section. On the other hand a reduc- K.  E,  ~ENSEN  AND  T.  FRANcIS~  JR.  635 
tion of antibody titer by 16- to 64-fold reflects a relatively prominent or major 
antigen in the mosaic while less prominent antigens, spatially or quantitatively, 
are mirrored by the 4- to 8-fold reductions of antibody titers. The information 
gained concerning  the relative  concentrations of these components expressed 
as major or minor status is given in Table VII for several Type A strains of 
influenza  virus. It is apparent that many antigens are often shared by these 
strains  in either minor or major status. Noteworthy too is the trend toward 
a continuing change in antigens expressed as a  major feature in the antigenic 
profiles.  But the fact that  the  components now considered representative of 
older strains  are readily demonstrable in recent strains  points out the prob- 
ability that variation can proceed in any direction. 
The antigenic mosaics of some of these strains derived from the same data 
are  pictorially  presented  in  a  different  manner  in  Fig.  7.  The  radial  lines 
spatially arranged on circles represent antigens demonstrated in the analyzed 
virus.  The  relative  concentration  of each antigen  is pictured by the length 
of these radii to indicate major or minor status. From these profiles the shared 
antigenic  relationship  between the  PR8  (1934) and  Weiss  (1943)  strains  is 
readily grasped,  and  the major  antigenic  differences  in  their  composites be- 
come equally apparent. And some of the older strains (Alaska,  BH, Hickcox) 
possess significant  amounts of antigens  most prominent  in  strains  of recent 
years. In the FM1 profile several different components are prominently featured 
and yet many of the antigens demonstrated in strains isolated at an earlier 
date are evident. The number of the old antigens reflected is seen to vary in 
the more recently isolated strains. The antigen represented by the 1951 strain 
is  again  readily  observed in  the  1953 isolations,  but  an  antigen  not  often 
expressed previously is also featured in a major role in the latter. 
Selection of Strains for a Complete Vaccine 
The selection  of strains of virus for inclusion  in a vaccine against influenza 
has been a  continuing  problem.  Information  gained from  the above studies 
again suggests that broad coverage can be obtained by combining strains whose 
profiles fall the range of known antigens through their dominant and secondary 
components.  From  the  data  summarized  in  Table  VII  it  appeared  that  a 
mixture  of  swine,  WS,  PR8,  Cat,  Weiss,  FM1,  and  Jessup  strains  would 
satisfy the need. Accordingly,  the pool of 18 sera which contained high levels 
of antibody to the entire complement of antigens was subjected to simultaneous 
absorption with 4 A.U. of each of these strains.  The  titer against  the  Type 
B, Lee, strain was unaltered, but all other antibody was absorbed except for 
small residues (1:4) against Talmey, BH, and Cam. It is apparent then that 
such a combination should be efficient in stimulating antibody to a wide range 
of antigens which have been identified  and probably to others which, currently 
less prominent, may be dominant later. The results also recommend the pro- 636  ANTIGENIC  COMPOSITION  OF  INFLUENZA  VIRUS 
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cedure for screening  strains for their antigenic potency and for prompt detec- 
tion of variants which might present quite different characteristics. 
Moreover, data,  to be published later,  show that  the significance  of cross- 
relationships between strains can be further illuminated by application of the 
method to the study of antibody in human sera.  It is of interest that single 
strains may actually remove all detectable antibody from the sera of persons 
who have had extensive experience  with influenza.  The influence of strains in 
indtlcing  or heightening  homologous and  heterologous antibody by vaccina- 
tion of man is also being subjected to analysis. 
DISCUSSION 
Application of the methods described here for antigenic analysis by absorp- 
tion of antibody has resulted in a more precise definition  of the shared compo- 
nents and  a  more complete analysis of the composite antigenic structure  of 
strains of influenza  virus than has been previously obtained. The demonstra- 
tion of many shared antigenic components in strains widely separated in time 
of isolation leads to the conclusion  that all Type A  strains probably possess 
the potential expression  of each of these shared antigens, any of which might 
become strain-dominant.  It  becomes obvious that  myriads  of  antigenically 
distinguishable  strains  could be found  by rearrangement  of  components  in 
space or quantity even if the number of components were limited to 18. This 
is a  very conservative estimate of the number of antigenic  components be- 
cause only 29 strains have been studied with these methods, and strains may 
be later encountered in which other components may be prominent. 
The  probability  of  the  appearance  of  completely unrelated  antigens  and 
complete disappearance of old antigens appears small.  Even with the limited 
number of strains studied there are no examples of the expression of an antigen 
not  demonstrated  in  strains  isolated  several years before, nor  are  antigens 
completely lost, never to reappear. Moreover, the interrelationships  are such 
as to retain characteristics of Type A virus in all the strains. 
Several  mechanisms  for  the  apparent  rearrangement  of  antigens  can  be 
suggested. Perhaps all the possible configurations  exist in a  pool of influenza 
virus molecules which are distributed  throughout  the world and from which 
highly infectious strains arise  to be spread in epidemics of the disease.  Higher 
antibody levels of the human population may tend to inhibit strains with major 
antigens  which  were  dominant  in  recently  prevalent  strains  and  to  select 
strains with different profiles for distribution. It is also possible that antibody 
may  act  directly  on  the  nucleoprotein  to  inhibit  the  formation  of  certain 
prosthetic  groups  or  indirectly  accelerate  the  formation  of other  particular 
chemical  groupings. 
The work of Burnet and Lind (29) and Hirst and Gotlieb (30) suggests an- 638  ANTIGENIC COMPOSITION  OZ INFLUENZA  VIRUS 
other  series  of reactions by  which antigenically different composites  may 
be selected. When critical concentrations of two strains of influenza virus are 
simulraneously inoculated into a  susceptible  host, another strain which con- 
rains components shared by the test strain may be recovered. Although these 
investigators believed the result to be a recombination of the heredity-directive 
forces from the "parent" strains in the new strain, it appears equally probable 
that  dynamic selective  processes  could be  involved.  The virus particles of 
any strain  are  heterogeneous, and  antigenic analysis of  these  suspensions 
reflect the  composition  of the majority.  If an  inoculum contains particles 
from two populations which are antigenically different but share many com- 
ponents, there may be mutual interference in the processes of replication of the 
representative  particles  from  each  strain  since  they  are  dissimilar,  while 
minority particles from either strain are multiplied. This could result in the 
recovery of strains  that have antigenic structures capable of reacting with 
specific sera prepared for both of the "parent" strains and feature antigens 
that were not well expressed in other strains. 
The results and concepts discussed here, in general, support the thesis  (31) 
that the vagaries of strain variation probably are not insurmountable in rela- 
tion to immuni~,ation procedures,  and effective prophylaxis against influenza 
should be available by incorporation of several strains with known antigenic 
profiIes in a vaccine to yield an antigenic mass in which all recognized compo- 
nents are adequately represented and which,  in  turn,  should stimulate  the 
production of antibody to protect against any possible  combination of anti- 
genic components in a strain of influenza virus of a given type. 
sum~Y 
The application of methods herein described for the absorption of antibody 
from sera by influenza virus adsorbed to erythrocytes has greatly facilitated 
absorption studies with this virus and has resulted in a more comprehensive 
demonstration of strain differences and relationships.  It is now evident  that 
there are at least 18 different antigenic components which can be measured in 
Type  A  strains  of  influenza  virus.  Utilization  of  quantitative  absorption 
technics allows  the simultaneous detection of variable quantities of several 
different antigens so that the antigenic composite of the strain is more clearly 
defined than was previously possible. The wide sharing of antigenic components 
leads to the conclusion that no completely new antigens have formed of late 
nor have the antigenic components of strains isolated several years ago disap- 
peared. Some mechanisms for antigenic variation among strains are suggested, 
and the significance of the variation in antigenic components is discussed  in 
relation to specifications for an effective vaccine. K.  E.  JENSEN AND T.  FRANCIS, JR.  639 
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